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Duringacutemyocardialinfarction(AMI),amongpatientswithTIMl3patency,




of TIMI3 patencybyPTCA(n= 16)or iv. thromtmlysis(n= 3) in 19patients




9 & 1daysin all petientaand6 weekalaterin 13patients.Echographicwall
motionscore(WMS)wasgradedfrom1 (normokineaia)to 3 (akinesla).
MCEgrade o 0.5 1 P
Aklneticeegments (day 9) 94% 83%a 41% 0.001
AVSraW WMS(day9) 2,9+ 0.04 2,7+ 0.1 2.1* 0.1 0.01
Akineticsegments (6 wesks) 87% 59%* 50”A 0.04
Averags WMS (6 wesks) 2.9 + 0.1 2.5 + 0.18 2.2 * 0.1 0,02
*p -Z0.05vscorrespondlngvalueat day 9. ap <0.05 vs perfusiongrade 1 segments
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Vi~inia, Charfotteaville, VA,USA
There is debate whethar LV dysfunction seen in chronic coronary artery
dieeaae (CAD) is due to repetitive stunning or hibernation. To address this
queation, wehavedavebped a caninemodelofchronicCADwhereameriod
constrictorsare placedon the proximalleft anteriordescending(LAD)and
left circumflex(LCX)arteries.Indwellingcathetersare placedin the AO
and LA and these are externalized.The dogsthen undergoradiolabeled
microspheremyocardialbloodflow(MBF)assessmentandregionalLVwall
thickeninganalysieby2Dechoeeriallyover3t06weeks.Thedogsarekilled
whenaevereglobal LVdysfunctionand dilatationis manifeat.We studied





dysfunctionin all 12bedsbythetimeof sacrifice.MBF(ml.amineg-’) in the
hibernatingbedsdeclinedfrom1.6+0.4 at baselineto 0.6+ 0.2at sacrifice
(p = < 0.01),whilethickeningdecreasedfrom31 + 5% to 10+ 4% (p <
0.01).In the stunnedbeds,MBF(mL.mln.g-’) was 1.4& 0.6 at baseline
and 1.1+ 0.2 at sacrifice(p = 0.3),whilethickeningdecreasedfrom33 +
II% t. 14 + 6y0(p ~ ().01).It is concludedthat bothrepetitive $tunnin9







M.Vaghetti,A. Cantaralli,G.Amoroao,M.Marfani.Institute of Cardiology
Univera/tyof Piae, /ta/y
In 10ptswithpreviouamyocardialinfarction(9malea,1female,meanage60
y), submittedto PTCAon the infarctrelatedvessel,intraconma~echocon-
trsar (IE) was comparedwith low doaeechodobuteminestresstest (ED)
results.IE and EDweraperformedbeforePTCA.An echo90 daysfollow
up wasobtainedin all pts. Myocardialperfusionwasassessedby IE with
a semiquantitativescorerangingfromO(noperfusion)to 3 (homoganaous
perfusion).EDwas carriedout by a digitalizedapproach.Results:41 out
JACC Febmary1997
of 160(25%)LVsegmentsshowedabnormalmotionbeforeEDand IE.ED
evidenceof viablemyocardiumwasobtainedin 24 out of 41; a normalper-
fusionpattern)(2 or 3 IE pattern)wasobservedin 20 (S3%).Amongthe 17
non-viableEDsegments,12 ahowadraducedor absentperfueion(Oor 1
IEpattern)(62%)while5 segmantsshowednormalperfuaion.IEallowedto
show25segmentswithnormalflowand16sagmentswithreducedorabsent
flow.After90 daysfollowup an improvementin wall motionwaa observed
in 75 and29%of viableand non viableED segmentsrespectively(speci-
ficity66%,sensitivity73%),On the otherhand,67% IE normallyperfused
segmentshaveshownan improvementof their motionand65%of hypoor
nonperfuaedsegmentaconfirmedthe absanceof viability(specificity72%,
sensitivity90%).Segments howingEDevidenceofviablemyocardiumand
IE2 or 3 scoreimprovedtheir motionafter PTCAin 62%of cases.In con-
clusion,IEshowsa bettersensitivitythanEDinthe evaluationof myocardial






T.Porter,S.Li,D.Kricsfeld,K. Kilzer.Univeraityof Nebraska Medics/
CenteL Omaha, Nebraska, USA
Themyocardialultrasoundcontrastdefectobsewadwithconventional(conv)
30 Hzframerates(FR)followingreperluaion(REP)of an occludedvessel
correlateswithinfarctsize(IS)onlywhenthe intravenous(IV)microbubbles
(MB)aregivenduringhyperemia.SinceconvFRdestroylargenumbersof
MB,we hypdhizedthat newerimagingtechniqueswhichreduceMB de-
structionIikatriggeredimaging(TI)willbemoreaensitivein identifyinginfarct
zonesfollowingREP.Totest this hypothesis,we gave IV psrfluorocarbon-
expasadsonicsteddextrosealbumin(PESDA)MB (0.0025-0.01ml/kg)to
11openchestdogswhohada sustained coronaryocclusion(range 1.6-2.5
hours)followedbyREP.After15minutesof reflow,contrastdefects(CD)ob-




Results: IS rangedfrom23t077% ofthetotalRA,andcorrelatedtheclos-
estwithrestingcontraetdefects(CD)usingTl, especiallydefectsdetermined
withextendadtimeintervalsbatweenFR(r= 0.96,standarderror0.4 cm2).
CDsizeduringLDDcorrelatedlesscloaelywith IS (r= 0.77). An example:.
,23%’













we assessedthe abilityof IV perfluonxarbon-exposedeonicateddextrose
albumin(PESDA)to consistentlyproduceMC in 110pts (age3S-S0yre,
weight47-106 kilogram). MCwaadeterminedbothvisually(O= no oon-
trast,1+= mild,and2+ = brightMC),andquantitativelyueinga 1-255 gray
scalaoff line.Safetywasassassedby measuringchanges(A) in oxygen
saturation(02 eat),meanarterialpressure(MAP),raspkatoryrata (rr), and
EKGbeforeandafterinjection.Fourdifferentimagingtechniques(IT)were
compared:30 Hertzandtriggered(transientreaponse)let harmonic(30-let
andTR1-lst)as well as 30 Hertzand triggered2nd harmonic(30-2ndand
TR1-2nd)usinga 1.7-2.5 Megahertzfundamentalfrequency.(;* p <0.05
comparedto othergroups;N= numberof ptsthatunderwenthe IT):
JACC Febmary1997 . . . . . . --- - .,..AL5S”1”KAC’1’S - Foster 481A
Mode N A02 Sat Arr AMAP # 2 + MC PMVI n1073 Nuclear Cardiology: Viability/lnotropic
30.lst 10 0.1 l 1.2 O*3 1 *9 1/10 8&7 stress
+E1-lat 5 0.1 * 1.4 O*3 3 l 10 1/ 5 10+ 6
30-2nd 22 0.1* 1.3 O*3 1 %8 2/22 21 * 14
TFfl-2nd 92 0.1i 1.3 O*3 1 &6 90/92$ 43+ 2*
No significantpatientcomplalntawerenotadwith cumulativedosesup
to 0.04ml/kgusinganyof the IT.Visual2+ MCwasachievedin over95%








EclipseHolmiumLTMRhas reportedlyresultedin reductionof ischemic
symptomsin patientswith end-stageIschemiccardiomyopathy.However,









thenallowedto recoverand wererestudied(Day2) at l-week (n =4) and






PI 11.4+ 6.3 0.64*OS4* 4.9* 1.9
TF 29+ 16 –21 *34* 11+ 18*
RLM 0.53*0.OS 0.17+O.lot 0.45l 0.3s










developadwhich is amallenoughto be introducedtransnaeelyin human
subjeofa(TNT).Oeeeasionally,trsnsnasalpassageisdifficult,eiaoeiatedwith
minordiscomfortor nasalmucosableeding.TocircumventheseIimitetiona,
we evafuatedthe uae of trananeaalincubationwith the new TNT probe
usingtwo differenttypes of nasalconduits.The first conduit is a hollow
plastictube which is introducedinto the nasalpassagewith subsequent
pessegeof the TNTprobethroughthis device.TheaacondConduitallows
aimultenaousintroductionof,ftreconduitandprobethusavoidingastep.This
customdevelopedconduitis a polyvinylchloridetubewitha distalnormally
closedlobedballendwhichselectivelyopeneto permitpassageof theTNT
probe.The proximalend of the thin walledtuba is ball shapedfor easier
probsinsertionandpassage.Westudied65 patientswithTNTdividedinto
3 groups.Thirtyeight patientswere intubatt+dwithouta nasalconduit,37
were Infubetadwith the first and 12 patientswith the secondgeneration
conduit.Transneealpeeeageof the prototypeprobewaapossiblein 76~0




witheaseasa oneetepmaneuverwiththe useof a newsecondgeneration
meal conduit.









stimulationi patientswith significantleft ventriculardysfunction(LVEFs
35%)weevaluateda populationof 70patients(56men),54 + 12yeareold,
including44withischemicheartdiseaae(IHD)and26withidiopathicdilated
cardiomyopathy(DCM).Radionuclideventriculogrephyincludeddetermina-
tionof LVEFat restandaftergradedinfusionof epinephrineor dobutemine
(inot).AverageLVEFvalueswere23 +7% at basellneand29+ 11%after
inotropicstimulation.
Duringa follow-upof 31 + 17months24 cardiacdeathsoccurred(13 in
IHDgroupand11in DCMgroup).Usinga cutoffof25%,inotropicLVEFwas
superiorto baselineLVEFindiscriminatingKaplanMeierestimatedsuwival.
Suwivalat 1, 2 and 3 years(95%Cl”for 3 years)weerespectively100%,
90%and86%(7I-1OO)for restLVEF? 25%,78%,69%and 61% (48-76)
for restLVEF< 25°A(p = 0.03),100%,91%and86%(77-99) for inotLVEF
? 25%and68%,56%and47?4(29-85)for inotLVEF< 25%(p < 0.0008).
$p~. $~







prognosticevaluationin patientswith importantleft ventriculardysfunction,
andmaybeuaefulin theselaetionof patientafor hearttransplant.
11073-52( DobLftSmineRadiOnuclideVentriculography:
Prediction of Ventricular Funotion Improvement





patients(pte)with ischemiccardiomyopathy(IC)dependingon the amount
of Contractilemyocerdialresewe.The useof low-dosedobutamine(DOB)
radionuclideventrfculogrsphy(RNV)intheassessmentoffunctionalcontrac-
tile resewehasnot beencriticallyevaluated.We prospectivelyatudisd35
ptswithIC(meanEF23 + 5%)andtriple-vesseldiseaseonemonthpriorto
CABG.All underwenta 2-dayprotocol:day 1- Tc99mseatamibi(SM)(25
mci)SPECTimagingat rest,performedfor viabilityeeoring(15aegments);
day2- RNVpriorto andduringinfusionof’5and10#k@gfmin of DOB.An
increaseof globalEFfromrestto DOB(AEF)wascalculated,andvalueof
10%wasconsideredas cutofffor predictivevalue.Twopts diedwithinone
monthofCABG.Therest(33pta)werefollowedfor 12+ 5 months.Ofthese,
16ahowedimprovement(AEFz 5%mean10+ 5%)and 17did not (AEF
< 5%mean-1 + 3%).Theresultspriorto CABGwere:
ImprovsdEF No improvedEF P
SM-ViabilityScore 7* 1 8k2 NS
Resting- EF (“A) 254C 5 22* 5 NS
EDV (ml) 193 l 50 212*49 NS
DOBAEF(%) 10*5 5*4 0.03
Thesensitivity,apecificify,positiveandnegativepredictivevaluesof DOB
RNVwere65%,92%,92%,and67%,respectively.Conclusions:DOBRNV
iaa usefulmethodto asseasandpredictfunctionalimprovementafterCABG
